Spontaneous acute tumor lysis syndrome (ATLS) was diagnosed in a 10-month-old female DBA/1J sentinel mouse with leukemic lymphoma. The mouse was unable to maintain balance and died shortly after being observed rolling around in its cage. Disseminated neoplastic disease, including a large cranial mediastinal mass, enlarged lymph nodes and splenomegaly, was present at necropsy. Histopathologic examination revealed widespread massive necrosis of lymphoblastic tumor cells, and widely disseminated microemboli composed of nuclear and cytoplasmic cell debris. Although ATLS is widely recognized as an oncologic emergency in humans, acute lesions of ATLS have not been described. The mechanical obstruction of capillary beds by microemboli originating from disintegrating necrotic tumor cells was the likely cause of clinical signs and death in this mouse. We propose that similar microemboli may contribute to the pathogenesis of the acute renal failure and other clinical signs associated with ATLS in humans. Recognition of spontaneous ATLS in laboratory animals is especially important in studies that assess the efficacy and/or toxicity of anticancer treatments, where early deaths due to ATLS might mistakenly be attributed to a direct test article effect.
INTRODUCTION
Acute Tumor Lysis Syndrome (ATLS) in humans is caused by the rapid destruction of malignant cells, with the subsequent massive release of cellular contents and breakdown products that overwhelms normal excretory and cell buffering mechanisms and produces an acute metabolic crisis. Spontaneous ATLS in humans is rare, as most cases are associated with intensive chemotherapy of large, highly proliferative lymphoid neoplasms. However, ATLS has been reported with a variety of tumor types and with treatment with corticosteroids, hormones, or cytokines. Due to the ever-increasing arsenal of highly effective chemotherapeutic agents, the incidence of ATLS is increasing (4, 6) . Clinically, ATLS is associated with hyperkalemia, hypocalcemia, hyperphosphatemia, and hyperuricemia. The most commonly reported cause of death in human ATLS patients is acute renal failure due to the flooding of excretory pathways by cellular breakdown products. There have been few reports of chemotherapyassociated ATLS in dogs and cats in the veterinary literature (3, 7, 8) but we found no reports of spontaneous cases. Here we present the acute lesions of presumptive spontaneous ATLS in a mouse. To the best of our knowledge, this is the first report describing the widely disseminated microemboli composed of nuclear and cytoplasmic debris derived from lysed tumor cells. We propose that the mechanical obstruction of capillary beds by these microemboli was the proximate cause of the neurologic signs in this mouse, and that similar microemboli may contribute to the pathogenesis of The views and findings contained herein are those of the authors and should not be construed as an official Department of the Army position, policy, or decision.
Address correspondence to: Dr. Peter Vogel, Division of Pathology, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, USA; e-mail: peter.vogel@na.amedd.army.mil acute renal failure and other clinical signs associated with the ATLS.
CASE REPORT
A 10-month-old female DBA/1J sentinel mouse weighing 16 g was observed rolling around in its cage and unable to right itself. The mouse died shortly after these signs were observed, and was then submitted for routine necropsy. No other abnormalities were reported in this mouse. The mouse was caged with 3 other sentinel mice, and it had adequate access to food and water. All of the mice in this colony are cared for and used humanely in compliance with the Animal Welfare Act and other Federal statutes and regulations relating to animals and experiments involving animals and in adherence to principles stated in the Guide for the Care and Use of Laboratory Animals, NRC Publication, 1996 edition. All procedures were reviewed and approved by the Institute's Animal Care and Use Committee, and performed in a facility accredited by the Association for Assessment and Accreditation of Laboratory Animal Care, International.
METHODS
Immediately after death, a full necropsy was performed and tissues were collected and fixed in 10% buffered formalin solution. Tissues collected included the brain, heart, kidneys, liver, intestines, lymph nodes, esophagus, uterus, spleen, and a large soft tissue mass from the cranial mediastinum. After fixing, the tissues were processed routinely and embedded into paraffin blocks. Then, 6 to 8 micrometer thick tissue sections were cut and stained with hematoxylin and eosin. After routine histologic evaluation, additional sections were cut and stained with Feulgen stain or Hoechst 33342 to identify and confirm the presence of DNA/nucleic acid in the microemboli. Selected areas of the lung were cut out of the paraffin block and processed for electron microscopy in order 486 Vol. 31, No. 5, 2003 SPONTANEOUS ACUTE TUMOR LYSIS SYNDROME 487 to better characterize the composition of the microemboli and neoplastic cells.
RESULTS
At gross necropsy disseminated neoplastic disease was evident. A large, white, irregular, soft mass was present at the base of the heart in the cranial mediastinum. The spleen was diffusely enlarged to approximately 3 times normal size and multiple lymph nodes throughout the body were enlarged up to 10 times normal size. The most notably affected nodes were the submandibular lymph nodes and mesenteric lymph nodes near the pancreas.
Lymphoma with evidence of leukemia was apparent histologically. The large cranial mediastinal mass was composed of sheets of small uniform round neoplastic cells characterized by a small amount of lightly basophilic cytoplasm and a central stippled, round to indented nucleus containing 1 to 2 indistinct nucleoli. Up to 90% of the neoplastic cells were necrotic, characterized by pyknotic nuclei and abundant karyorrhectic debris ( Figure 1 ). The spleen and multiple lymph nodes were diffusely infiltrated with neoplastic, and often necrotic, round cells that effaced the normal architecture. In addition, neoplastic cells infiltrated the brain (meninges), heart (epicardium) and liver (hepatic portal areas extending into the sinusoids- Figure 2 ). Neoplastic cells were also present throughout the vascular system. Numerous viable and apoptotic lymphoid cells were observed in the hepatic sinuses and within pulmonary capillaries and alveolar spaces ( Figures 7A and 7B ).
In virtually all tissues examined, there were multifocal variably sized emboli composed of deeply basophilic material variably admixed with eosinophilic material. These emboli were particularly common in the lung, where large pulmonary vessels contained mixed emboli ( Figure 3 ) while most alveolar capillaries were occluded by basophilic microemboli ( Figure 4 ). Other severely affected tissues included the kidneys and the brain ( Figure 5 ). Most microemboli were composed of homogeneous, acellular and deeply basophilic material resembling aggregated chromatin ( Figure 2 ). The basophilic emboli were negative for calcium with Von Kossa's stain, but their positive fluorescent blue staining ( Figure 6 ) with Hoechst 33342 (Molecular Probes, Eugene, OR) and intense red-purple staining of with Feulgen stain confirmed that they contained deoxyribonucleic acids (DNA), presumably derived from the nuclear chromatin of necrotic tumor cells. Hoechst 33342 is a specific stain for AT-rich regions of double-stranded DNA (9) .
By electron microscopy, the basophilic emboli had a uniform electron dense appearance similar to that of nuclear chromatin in adjacent apoptotic lymphocytes (Figures 7C and 7D). Mixed emboli had a more variegated appearance, in which small amounts of the basophilic nuclear material was trapped within larger clumps of eosinophilic granular debris ( Figure 3 ). Ultrastructurally, the eosinophilc granular debris appeared to be derived from aggregated cytoplasmic fragments of necrotic tumor cells ( Figure 7D ).
DISCUSSION
ATLS is precipitated by the rapid, massive necrosis of tumor cells and subsequent release of cellular contents, resulting in metabolic crisis that, if untreated, can lead to mul-tisystemic organ failure (1) . Although spontaneous onset of ATLS does occur, the syndrome is most often associated with aggressive chemotherapy of lymphoproliferative malignancies. Factors that predispose patients to an increased risk for ATLS include not only the type of cancer (2, 5) , but also increased tumor mass bulk (1, 4) sensitivity to drug therapy (4), serum LDH above 600 iu (associated with areas of tumor ischemia, and used to predict tumor bulk) (2, 4, 6) , renal status (1, 4) , serum uric acid levels (1, 4) , and abdominal location of the neoplasm (1, 2, 6) . There is increased risk of ATLS with any preexisting neoplastic condition that can result in either increased cell death and/or a reduced capacity to metabolize and eliminate cell breakdown products. The mouse in this report had widely disseminated lymphoblastic leukemic lymphoma. The extraordinarily large tumor load (with a cranial mediastinal mass partially filling the thoracic cavity and metastases to abdominal organs such as the spleen and liver) increased the risk of ATLS. Since this sentinel mouse did not receive treatments of any type, we hypothesize that spontaneous ATLS may have been precipitated by the physiological stresses imposed by the large tumor burden. It is known that corticosteroids, cytokines, and hormone therapies have triggered ATLS episodes in humans (1, 4) . It is possible that a stress-induced surge of endogenous glucocorticoids precipitated the acute tumor lysis episode and rapid death in this mouse. However, whether ATLS is treatment-related or spontaneous, recognition of the syndrome in laboratory animals is critically important in studies intended to evaluate the efficacy and/or toxicity of anticancer treatments, where early deaths due to ATLS might otherwise be attributed to test article toxicity.
Regardless of its precipitating cause, ATLS in humans is characterized metabolically by hyperkalemia, hypocalcemia, hyperphosphatemia, and hyperuricemia. Hyperkalemia is often present before (at 24-48 hours) other metabolic alterations are detectable. The elevated serum potassium is attributed to decreased ATPase function (in the Na+/K+ pump) leading to increased K+ leakage. Hyperkalemia can result in arrhythmias, syncope, or sudden death (4) . Hypocalcemia occurs at around 48-96 hours as a direct response to hyperphosphatemia, and is usually manifested as neurologic or muscular disturbances such as tetany (4, 6) . In addition, calcium and phosphate ions can form precipitates in the kidneys that contribute to acute renal failure (2, 6) . Moreover, the release and subsequent breakdown of massive amounts of nuclear DNA can result in hyperuricemia, which contributes to acute renal failure secondary to an acute urate nephropathy and tubular necrosis (1, 4, 6) .
The mouse in this study was seen rolling in its cage and unable to right itself before death. This abnormal behavior may have been due either to the metabolic disturbances such as hyperkalemia and hypocalcemia, which can cause cardiac arrest and seizure-like activity, or to hypoxia as a result of compromised blood flow caused by the blockage of pulmonary or cerebral capillaries by the microemboli.
In ATLS, massive amounts of nephrotoxic cellular waste products essentially overload the capacity of the body's normal excretory mechanisms (2, 4) . The most frequently reported cause of death in human ATLS patients is acute oliguric renal failure due to an acute urate nephropathy (2, 4) . In these patients, mechanisms for uric acid excretion and Circulating lymphocyte (ly) shows early apoptotic changes, with condensation and margination of nuclear chromatin that is similar in appearance to the adjacent intravascular but extracellular electron dense material (arrow). 11,300×. (C) A capillary lumen is occluded with a granular electron dense material consistent with dispersed chromatin. 9,000×. (D) Cytoplasmic fragments (arrow) are present next to the electron dense extracellular material (arrowhead). 9,000×. processing nucleic acid by-products are overwhelmed (5) . Normally, free nucleotides are broken down into purine and pyrimidine bases. Pyrimidines are broken down and recycled as amino acids, while purines are converted by xanthine oxidase in the liver from hypoxanthine and xanthine to uric acid, which is excreted in the urine (6) . Massive tumor cell lysis presents excessive amounts of nucleic acids to the liver, resulting in increased production of uric acid. If uric acid levels increase while pH decreases, the less soluble urates begin to deposit in the tissues, most notably in the kidneys (4) where the crystals cause blockage and tubular necrosis (2) . Neither crystal nor renal tubular necrosis was seen in this mouse, but microemboli and necrotic debris were evident within the glomerular capillaries and interstitial vessels. Poor renal perfusion due to these emboli could have eventually led to the oliguric renal failure characteristic of ATLS. By impeding renal blood flow, microemboli in these capillaries can directly cause oliguria and tissue hypoxia. These conditions favor the formation of uric acid crystals and necrosis of tubular epithelium, while simultaneously impairing regulation of serum electrolytes and clearance of toxic metabolites. We believe that this mouse died early in the progression of ATLS, well before the changes associated with urate crystal deposition and renal tubular necrosis could develop.
Unique to this case was the widespread presence of deeply basophilic homogeneous acellular material within blood vessels and among karyorrhectic tumor debris. The positive Hoechst 33342 and Feulgen staining, and ultrastructural findings provide convincing evidence that the basophilic microemboli are composed of DNA. There are several possible explanations for the fact that the widely disseminated DNA and cell debris emboli observed in this mouse have not been previously reported in ATLS in humans or other species. First, most reports of ATLS in humans do not address lesions, but are focused on the clinical management and treatment of the syndrome, and therefore deal with the clinical diagnostic and prognostic indicators. The relatively few reports that do address the pathology of ATLS are based on the lesions found at death, which typically occurs several days to weeks after the onset of ATLS. At that point in time, most reported lesions are present in the kidney and are attributed to urate crystal deposition in the renal medulla. There is general agreement that the hyperuricemia of ATLS is a reflection of the tremendous amount of nucleic acid breakdown and metabolism that occurs following rapid necrosis of overwhelming tumor burdens. We hypothesize that the lack of reported DNA microemboli in previous reports is explained primarily by the later stage of ATLS examined, and possibly by the relatively rapid breakdown and clearance of free nucleic acids by endogenous nucleases. These nucleases would continue to function and dissolve DNA microemboli even after death, thus even with acute ATLS, DNA microemboli might dissolve given a sufficiently long interval between death and tissue fixation.
To the best of our knowledge, this is the first report of spontaneous ATLS in the veterinary literature and the first describing the acute lesions of ATLS, which are characterized by widely disseminated microemboli composed of nuclear and cytoplasmic debris derived from lysed tumor cells. We propose that DNA microemboli contribute to the development of urate nephropathy, the most common cause of ATLS associated mortality in people. Recognition of spontaneous ATLS in experimental laboratory animals is critically important in studies that assess the efficacy and/or toxicity of compounds, because early deaths due to this syndrome might mistakenly be attributed to a direct test article effect.
